AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3125788
Drug: Fleroxacin 200
RxNorm normalized name: fleroxacin 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 200 mg oral dose
Trial: 3144542
Drug: Fleroxacin 400
RxNorm normalized name: fleroxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 400 mg oral dose
Trial: 3125788
Drug: Fleroxacin multiple
RxNorm normalized name: fleroxacin
DrugBank: Fleroxacin (DB04576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin multiple dosing of 800 or 1,200 mg once a day over 10 days
Trial: 27630014
Drug: Omega-3 PUFAs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 PUFAs (1,200 mg eicosapentaenoic acid and 600 mg docosahexaenoic acid daily)
Trial: 10334517
Drug: 5‐FU infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5‐FU infusion and bolus CF with standard whole pelvic RT
Trial: 10334517
Drug: Oral HU
RxNorm normalized name: Hu-PHEC Liver
DrugBank: Hu-PHEC Liver (DB18347)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral HU with standard whole pelvic RT
Trial: 23983725
Drug: Vapocoolant spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vapocoolant spray before vaccination
Trial: 21565328
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment (CBT) with interoceptive exposure (IE) to visceral sensations
Trial: 15554982
Drug: Propofol administered
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol administered by registered nurses
Trial: 7880661
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg i.m. injection 1-2 h before operation
Trial: 7880661
Drug: Diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 75 mg i.m. immediately after surgery
Trial: 28263765
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone (50mg)
Trial: 18469247
Drug: Caffeinated coffee
RxNorm normalized name: Coffee bean
DrugBank: Coffee bean (DB10525)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeinated coffee (5 mg/kg) with low glycemic index meal
Trial: 10812390
Drug: Smectite (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smectite (2 x 6 g daily) in subgroup with small bowel volume <= 837.5 ml
Trial: 10812390
Drug: Placebo in
RxNorm normalized name: placebo INTRAVEN VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo in subgroup with small bowel volume <= 837.5 ml
Trial: 10812390
Drug: Smectite (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smectite (2 x 6 g daily) in subgroup with small bowel volume > 837.5 ml
Trial: 10812390
Drug: Placebo in
RxNorm normalized name: placebo INTRAVEN VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo in subgroup with small bowel volume > 837.5 ml
Trial: 20079321
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg adalimumab
Trial: 19702711
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg triamcinolone alone
Trial: 19702711
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg triamcinolone plus sequential laser
Trial: 16749588
Drug: Hydrochlorothiazide 50
RxNorm normalized name: hydrochlorothiazide 50 MG
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 50 mg/day (Group B)
Trial: 15310446
Drug: Customary antihypertensive
RxNorm normalized name: ANTIHYPERTENSIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Customary antihypertensive treatment
Trial: 1100294
Drug: Lirutrin (measles‐mumps‐rubella
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lirutrin (measles‐mumps‐rubella live, attenuated virus vaccine)
Trial: 25394681
Drug: BCAA and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCAA and zinc-enriched supplementation (6,400 mg/day BCAAs and 10 mg/day zinc)
Trial: 16443054
Drug: Adapalene gel
RxNorm normalized name: Adapalene Gel
DrugBank: Adapalene (DB00210)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adapalene gel 0.1%
Trial: 11845949
Drug: Tretinoin gel
RxNorm normalized name: Tretinoin Gel
DrugBank: Tretinoin (DB00755)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tretinoin gel 0.025%
Trial: 8988956
Drug: Pindolol (5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (5.0 mg b.i.d. or 2.5 mg t.i.d.)
Trial: 23566058
Drug: Oligonol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oligonol (100 mg)
Trial: 17127546
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg IV cocaine
Trial: 17127546
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg IV cocaine
Trial: 12824826
Drug: Laser photocoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser photocoagulation therapy
Trial: 2343728
Drug: Midazolam 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam 0.3 mg/kg
Trial: 2938518
Drug: 0.14 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.14 mg/kg of midazolam (midazolam hydrochloride 5 mg/ml)
Trial: 2938518
Drug: 0.29 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.29 mg/kg diazepam (Valium 5 mg/ml)
Trial: 18502245
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy for depression
Trial: 28810355
Drug: Cognitive-affective preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-affective preparation session
Trial: 25270545
Drug: Fixed-volume implant
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-volume implant in 1 breast and an adjustable-volume implant in the other
Trial: 25270545
Drug: Two fixed-volume
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two fixed-volume implants of different sizes
Trial: 22920839
Drug: Sling exercise
RxNorm normalized name: fu ling
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sling exercise therapy (ST)
Trial: 30888702
Drug: Anti-RPA194 antibodies
RxNorm normalized name: Anti-VEGF monoclonal antibody
DrugBank: Bevacizumab (DB00112)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Anti-RPA194 antibodies
Trial: 8609324
Drug: Intravenous amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amiodarone
Trial: 7734467
Drug: Continuity by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuity by having the intake therapist become the treatment therapist
Trial: 2659955
Drug: Nandrolone decanoate
RxNorm normalized name: Nandrolone Decanoate
DrugBank: Nandrolone decanoate (DB08804)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nandrolone decanoate (50 mg i.m. every 3 weeks for 12 months)
Trial: 17083882
Drug: Topical calcineurin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical calcineurin inhibitors (pimecrolimus and tacrolimus)
Trial: 17083882
Drug: FDA black
RxNorm normalized name: acid black 52
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDA black box warning on topical calcineurin inhibitors
Trial: 25992279
Drug: iloprost 5.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iloprost 5.0 µg
Trial: 25992279
Drug: iloprost 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iloprost 2.5 µg or 5.0 µg in iPAH subset
Trial: 24617227
Drug: Regular treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular treatment of diabetes (Control group)
Trial: 12624551
Drug: Epidural anesthesia
RxNorm normalized name: Epidural Anesthesia Tray
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural anesthesia (20 ml 0.375% bupivacaine through L(3‐4) inter‐space)
Trial: 9509181
Drug: Chloroquine/Chlorpheniramine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine/Chlorpheniramine combination
Trial: 28729021
Drug: Ceritinib 750
RxNorm normalized name: Ceritinib
DrugBank: Ceritinib (DB09063)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ceritinib 750 mg fasted
Trial: 19325998
Drug: Cold-water-spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold-water-spray
Trial: 16295047
Drug: lercanidipine 10-20
RxNorm normalized name: lercanidipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lercanidipine 10-20 mg/day
Trial: 16295047
Drug: ramipril 5-10
RxNorm normalized name: ramipril 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ramipril 5-10 mg/day
Trial: 11408852
Drug: Amoxicillin, 500
RxNorm normalized name: Amoxicillin, 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin, 500 mg, three times daily for 7 days
Trial: 3654947
Drug: SV vaccine
RxNorm normalized name: RSV VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SV vaccine (one dose)
Trial: 3654947
Drug: SV vaccine
RxNorm normalized name: RSV VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SV vaccine (two doses)
Trial: 3654947
Drug: WV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WV vaccine (two doses)
Trial: 3654947
Drug: Both vaccines
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both vaccines (one or two doses)
Trial: 3654947
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose (one month after first dose)
Trial: 25314004
Drug: Calcium-collagen chelate
RxNorm normalized name: calcium amino acid chelate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium-collagen chelate (CC) dietary supplement (5g containing 500mg of elemental calcium and 200IU vitamin D)
Trial: 18474769
Drug: Low-vision rehabilitation
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-vision rehabilitation program including low-vision examination, counseling, prescription and provision of low-vision devices, and 6 weekly sessions with a low-vision therapist.
Trial: 10668769
Drug: Gabapentin 900
RxNorm normalized name: gabapentin 900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin 900 mg orally three times a day
Trial: 7903218
Drug: Tertatolol 5
RxNorm normalized name: tertatolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tertatolol 5 mg
Trial: 8095894
Drug: Tertatolol 5
RxNorm normalized name: tertatolol 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tertatolol 5 mg + Prazosin 1 mg
Trial: 799569
Drug: Prazosin 1
RxNorm normalized name: prazosin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin 1 mg
Trial: 2137076
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of drugs
Trial: 3090959
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase (1,500,000 U in 30 mn)
Trial: 3090959
Drug: Conventional heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional heparin therapy
Trial: 8044944
Drug: Intravenous streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous streptokinase
Trial: 30996007
Drug: Nivolumab 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nivolumab 3 mg/kg every 2 weeks for up to 24 months
Trial: 23031804
Drug: TEASAP (Treatment-Emergent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TEASAP (Treatment-Emergent Activation and Suicidality Assessment Profile)
Trial: 15474758
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg buccal estradiol
Trial: 15474758
Drug: 0.05, 0.1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.05, 0.1, 0.2 mg buccal estradiol
Trial: 6387888
Drug: Metoprolol (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (50-100 mg twice daily)
Trial: 16296711
Drug: Diltiazem (60-120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (60-120 mg three times daily)
Trial: 9421122
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with ranitidine 300 mg b.i.d and clarithromycin 750 mg b.i.d, plus lymecycline 300 mg b.i.d (Group B)
Trial: 8050697
Drug: Bismuth 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bismuth 240 mg
Trial: 8050697
Drug: Ranitidine 150
RxNorm normalized name: ranitidine 150 MG
DrugBank: Ranitidine (DB00863)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ranitidine 150 mg + Bismuth 240 mg
Trial: 30234149
Drug: Tofacitinib (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tofacitinib (5 mg twice daily)
Trial: 4413081
Drug: Prednisone, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone, 3 mg/kg per day for 10 days
Trial: 4413081
Drug: Sodium salicylate,
RxNorm normalized name: Sodium Salicylate, compounding powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium salicylate, 100 mg/kg per day for 10 days
Trial: 31765110
Drug: lisdexamfetamine 20
RxNorm normalized name: lisdexamfetamine 20 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lisdexamfetamine 20 mg on Day 1, then 20 mg/d (Days 4-8), 50 mg/d (Days 9-13), 70 mg/d (Days 14-18)
Trial: 23465055
Drug: fesoterodine 4
RxNorm normalized name: fesoterodine 4 mg oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fesoterodine 4 mg once daily for the first 4 weeks, with an option to increase to 8 mg once daily for the remaining 8 weeks
Trial: 23465055
Drug: fesoterodine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: fesoterodine treatment
Trial: 21430035
Drug: Programmed intermittent
RxNorm normalized name: Program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Programmed intermittent bolus 2.5 mL every 15 minutes (2.5/15)
Trial: 19301089
Drug: Risedronate (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Risedronate (35 mg/week), calcium (1,000 mg/day), and vitamin D (400 IU/day) for 12 months
Trial: 19301089
Drug: Calcium (1,000
RxNorm normalized name: calcium carbonate 390 mg calcium (1,000 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (1,000 mg/day) and vitamin D (400 IU/day)
Trial: 17049060
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (maintenance CsA dose)
Trial: 23348843
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate
Trial: 9701531
Drug: Rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 20 mg
Trial: 9701531
Drug: Rabeprazole 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 40 mg
Trial: 9322642
Drug: Cefetamet-pivoxil (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefetamet-pivoxil (2 gm single oral dose)
Trial: 8418401
Drug: Carotid endarterectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carotid endarterectomy plus optimal medical treatment (aspirin) (surgical group; n=211)
Trial: 23910233
Drug: Treatment stoppage
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment stoppage due to side effects
Trial: 22089885
Drug: Standard Multidisciplinary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Multidisciplinary Medical Therapy (MT)
Trial: 11417777
Drug: Transdermal nicotine
RxNorm normalized name: nicotine Transdermal System
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal nicotine patch
Trial: 27994503
Drug: Far-Infrared Radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Far-Infrared Radiation (FIR) therapy applied for 40 minutes during each hemodialysis session, three times per week for six months.
Trial: 21689141
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy with amoxicillin, clarithromycin and lansoprazole twice daily for 2 weeks
Trial: 21689141
Drug: Dual therapy
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual therapy with amoxicillin and lansoprazole three times daily for 2 weeks
Trial: 17703640
Drug: Fondaparinux 2.5
RxNorm normalized name: FONDAPARINUX 2.5MG/0.5ML INJ SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fondaparinux 2.5 mg daily
Trial: 15901045
Drug: Coated tablet
RxNorm normalized name: COATED TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coated tablet formulation B (5 mg finasteride)
Trial: 10856145
Drug: Zafirlukast 20
RxNorm normalized name: zafirlukast 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast 20 mg twice daily
Trial: 1641497
Drug: Adjunctive imipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive imipramine added to ongoing medication regimen of fluphenazine decanoate and benztropine
Trial: 2371372
Drug: Adjunctive imipramine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive imipramine
Trial: 25256660
Drug: Alirocumab 75
RxNorm normalized name: alirocumab 75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab 75 mg via subcutaneous injection into the thigh
Trial: 17916813
Drug: Standard ambulance
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard ambulance transfer and treatment
Trial: 12143944
Drug: Oral nitrates
RxNorm normalized name: Nitrate
DrugBank: Nitrate (DB14049)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nitrates (n=504)
Trial: 12143944
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of oral and transdermal nitrates (n=60)
Trial: 9989541
Drug: DASH combination
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DASH combination diet
Trial: 7476284
Drug: Insulin/glucose infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin/glucose infusion at 0.025/2.0 U/kg.h and mg/kg.min
Trial: 7476284
Drug: Insulin/glucose infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin/glucose infusion at 0.050/3.5 U/kg.h and mg/kg.min
Trial: 7476284
Drug: Insulin/glucose infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin/glucose infusion at 0.100/6.0 U/kg.h and mg/kg.min
Trial: 7476284
Drug: Insulin/glucose infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin/glucose infusion at 0.200/8.0 U/kg.h and mg/kg.min
Trial: 2179134
Drug: Cefotaxime at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime at a dosage of 2 x 3 g/day for ten days
Trial: 10722441
Drug: Penicillin G
RxNorm normalized name: penicillin G
DrugBank: Benzylpenicillin (DB01053)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin G
Trial: 450561
Drug: Oral safflower
RxNorm normalized name: SAFFLOWER
DrugBank: Safflower (DB10905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral safflower oil (1 gm/kg/day)
Trial: 20142306
Drug: 10 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 μg dDAVP bolus (over 1 min)
Trial: 19261236
Drug: Alcohol (moderate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol (moderate dose)
Trial: 12198057
Drug: Parecoxib 40
RxNorm normalized name: Parécoxib
DrugBank: Parecoxib (DB08439)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Parecoxib 40 mg IV
Trial: 16428536
Drug: Methylprednisolone 125
RxNorm normalized name: methylprednisolone 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 125 mg IV
Trial: 8159194
Drug: Imipramine at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine at a dose of 50 mg nightly
Trial: 8159194
Drug: Clonidine at
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine at a dose of 0.1 mg twice daily
Trial: 1629885
Drug: Enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (20 mg/day)
Trial: 17015043
Drug: Smoking cessation
RxNorm normalized name: Zyban 150 MG Smoking Cessation 12 HR Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking cessation coupled with the use of an inhaled bronchodilator
Trial: 9207721
Drug: Oral immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunotherapy with encapsulated short ragweed extract
Trial: 3532799
Drug: Gestrinone 5
RxNorm normalized name: gestrinone
DrugBank: Gestrinone (DB11619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestrinone 5 mg capsules twice weekly (Group A)
Trial: 3532799
Drug: Gestrinone 2.5
RxNorm normalized name: gestrinone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestrinone 2.5 mg capsules three times weekly (Group B)
Trial: 3532799
Drug: Gestrinone 2.5
RxNorm normalized name: gestrinone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestrinone 2.5 mg vaginal tablets three times weekly (Group C)
Trial: 3532799
Drug: Gestrinone treatment
RxNorm normalized name: gestrinone
DrugBank: Gestrinone (DB11619)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gestrinone treatment overall
Trial: 31758329
Drug: Continuous regional
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous regional arterial infusion (CRAI) of nafamostat mesilate (NM)